Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis: week 96 results of a phase II, randomised, multicentre trial

被引：0

作者：

Kappos, L.

Li, D.

Calabresi, P.

O'Connor, P.

Bar-Or, A.

Barkhof, F.

Yin, M.

Leppert, D.

Glanzmann, R.

Tinbergen, J.

Hauser, S. L.

机构：

[1] Univ Basel Hosp, CH-4031 Basel, Switzerland

[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[3] Johns Hopkins Univ, Baltimore, MD USA

[4] Univ Toronto, Toronto, ON, Canada

[5] McGill Univ, Montreal, PQ, Canada

[6] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands

[7] Genentech Inc, San Francisco, CA 94080 USA

[8] F Hoffmann La Roche Ltd, Basel, Switzerland

[9] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P462

引用

页码：S194 / S195

页数：2